APVO Gets Buyout Offer, PFE/BNTX' COVID Shot 95% Effective, CORT Gets Favorable PTAB Ruling

RTT News

by Super Admin 23 Views

Today's Daily Dose brings you news about the buyout offer received by Aptevo, updated efficacy data of Pfizer/BioNTech's COVID-19 vaccine candidate, Corcept receiving a favorable ruling from Patent Trial & Appeal Board related to the U.S. Patent '214 covering Korlym, Aquestive's Type A meeting with FDA, and regulatory update related to CorMedix' Defencath.